InvestorsHub Logo
icon url

frrol

09/02/17 10:53 PM

#195552 RE: scottsmith #195550

Yes, it was double blinded as well. They did give some unusually specific results, but it is a smaller, exploratory trial that they must have had greater control of. I don't expect this from the P trial. We'll see.
icon url

Scottwny

09/03/17 12:21 AM

#195555 RE: scottsmith #195550

My guess is because those OM patients had already finished the trial, IPIX was able to unblind which group they were in (I have no clinical trial experience, this is just a guess).

I'm assuming if we only see 6 week data from P, no one will have technically finished the trial at 6 weeks, so we can't unblind the data. If we get a mixture of data, then maybe we get some unblinded data from those who have finished???